PDCD1 and neoplasm: FMT from ICI-responsive tumor patients into sterile or antibiotic-treated mice can improve the antitumor effect of the programmed cell death protein 1 (PD-1) blockade, whereas FMT from unresponsive patients does not show any improvement in antitumor activity (56).